Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

67 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Abiraterone in low-volume metastatic hormone-sensitive prostate cancer. Authors' reply.
Borque-Fernando A, Calleja-Hernández MA, Cózar-Olmo JM, Gómez-Iturriaga A, Pérez-Fentes DA, Puente-Vázquez J, Rodrigo-Aliaga M, Unda M, Álvarez-Ossorio JL. Borque-Fernando A, et al. Among authors: gomez iturriaga a. Actas Urol Esp (Engl Ed). 2023 Jul-Aug;47(6):392-393. doi: 10.1016/j.acuroe.2023.04.014. Epub 2023 Jun 8. Actas Urol Esp (Engl Ed). 2023. PMID: 37301369 English, Spanish. No abstract available.
Smartphones and tablets: Reshaping radiation oncologists' lives.
Gomez-Iturriaga A, Bilbao P, Casquero F, Cacicedo J, Crook J. Gomez-Iturriaga A, et al. Rep Pract Oncol Radiother. 2012 Aug 29;17(5):276-80. doi: 10.1016/j.rpor.2012.08.001. eCollection 2012 Sep. Rep Pract Oncol Radiother. 2012. PMID: 24669308 Free PMC article. Review.
Dosimetric analysis of the patterns of local failure observed in patients with locally advanced non-small cell lung cancer treated with neoadjuvant chemotherapy and concurrent conformal (3D-CRT) chemoradiation.
Moreno-Jiménez M, Aristu J, López-Picazo JM, Ramos LI, Gúrpide A, Gómez-Iturriaga A, Valero J, Martínez-Monge R. Moreno-Jiménez M, et al. Radiother Oncol. 2008 Sep;88(3):342-50. doi: 10.1016/j.radonc.2008.05.019. Epub 2008 Jun 14. Radiother Oncol. 2008. PMID: 18558448
A multidisciplinary consensus statement on the optimal pharmacological treatment for metastatic hormone-sensitive prostate cancer.
Borque-Fernando A, Calleja-Hernández MA, Cózar-Olmo JM, Gómez-Iturriaga A, Pérez-Fentes DA, Puente-Vázquez J, Rodrigo-Aliaga M, Unda M, Álvarez-Ossorio JL. Borque-Fernando A, et al. Among authors: gomez iturriaga a. Actas Urol Esp (Engl Ed). 2023 Mar;47(2):111-126. doi: 10.1016/j.acuroe.2022.12.004. Epub 2023 Jan 28. Actas Urol Esp (Engl Ed). 2023. PMID: 36720305 English, Spanish.
Consensus on management of castration-resistant prostate cancer on behalf of the Urological Tumours Working Group (URONCOR) of the Spanish Society of Radiation Oncology.
Gómez-Caamaño A, González-San Segundo C, Henríquez I, Maldonado X, Zapatero A; Expert Panel for the Consensus on Management of Castration-Resistant Prostate Cancer 2017, Urological Tumours Working Group (URONCOR), Spanish Society of Radiation Oncology (SEOR). Gómez-Caamaño A, et al. Clin Transl Oncol. 2019 Apr;21(4):420-432. doi: 10.1007/s12094-018-1940-2. Epub 2018 Oct 6. Clin Transl Oncol. 2019. PMID: 30293231
Salvage brachytherapy for locally recurrent prostate cancer after single-fraction 19 Gy high-dose-rate brachytherapy: toxicity, prostate-specific antigen kinetics, and cancer control.
Mayrata E, Espinosa JM, Büchser D, Casquero F, Suárez F, González A, Minguez P, Pérez JF, Miguel IS, Cacicedo J, Gómez-Iturriaga A. Mayrata E, et al. J Contemp Brachytherapy. 2021 Feb;13(1):12-17. doi: 10.5114/jcb.2021.103581. Epub 2021 Feb 18. J Contemp Brachytherapy. 2021. PMID: 34025731 Free PMC article.
67 results